Peptide YY (PYY) Gene Polymorphisms in the 3′-Untranslated and Proximal Promoter Regions Regulate Cellular Gene Expression and PYY Secretion and Metabolic Syndrome Traitsin Vivo
Open Access
- 1 November 2009
- journal article
- other
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 94 (11) , 4557-4566
Abstract
Rationale: Obesity is a heritable trait that contributes to hypertension and subsequent cardiorenal disease risk; thus, the investigation of genetic variation that predisposes individuals to obesity is an important goal. Circulating peptide YY (PYY) is known for its appetite and energy expenditure-regulating properties; linkage and association studies have suggested that PYY genetic variation contributes to susceptibility for obesity, rendering PYY an attractive candidate for study of disease risk. Design: To explore whether common genetic variation at the human PYY locus influences plasma PYY or metabolic traits, we systematically resequenced the gene for polymorphism discovery and then genotyped common single-nucleotide polymorphisms across the locus in an extensively phenotyped twin sample to determine associations. Finally, we experimentally validated the marker-on-trait associations using PYY 3′-untranslated region (UTR)/reporter and promoter/reporter analyses in neuroendocrine cells. Results: Four common genetic variants were discovered across the locus, and three were typed in phenotyped twins. Plasma PYY was highly heritable (P < 0.0001), and genetic pleiotropy was noted between plasma PYY and body mass index (BMI) (P = 0.03). A PYY haplotype extending from the proximal promoter (A-23G, rs2070592) to the 3′-UTR (C+1134A, rs162431) predicted not only plasma PYY (P = 0.009) but also other metabolic syndrome traits. Functional studies with transfected luciferase reporters confirmed regulatory roles in altering gene expression for both 3′-UTR C+1134A (P < 0.001) and promoter A-23G (P = 0.0016). Conclusions: Functional genetic variation at the PYY locus influences multiple heritable metabolic syndrome traits, likely conferring susceptibility to obesity and subsequent cardiorenal disease. Genetic variation in peptide YY (PYY) contributes to susceptibility for obesity, as illustrated by identification of polymorphisms that confer functional changes in gene expression.Keywords
This publication has 51 references indexed in Scilit:
- Six new loci associated with body mass index highlight a neuronal influence on body weight regulationNature Genetics, 2008
- Common and rare variants in multifactorial susceptibility to common diseasesNature Genetics, 2008
- The satiety hormone peptide YY as a regulator of appetiteJournal of Clinical Pathology, 2008
- MicroRNAs repress translation of m7Gppp-capped target mRNAs in vitro by inhibiting initiation and promoting deadenylationGenes & Development, 2007
- RegRNA: an integrated web server for identifying regulatory RNA motifs and elementsNucleic Acids Research, 2006
- Haploview: analysis and visualization of LD and haplotype mapsBioinformatics, 2004
- Haplotype reconstruction from genotype data using Imperfect PhylogenyBioinformatics, 2004
- To Eat or Not to Eat — How the Gut Talks to the BrainNew England Journal of Medicine, 2003
- Inhibition of Food Intake in Obese Subjects by Peptide YY3–36New England Journal of Medicine, 2003
- Multiple Sequence Alignment Using ClustalW and ClustalXCurrent Protocols in Bioinformatics, 2002